Norovirus RNA (2 Challenges) EQA/PT Scheme

To assess the specificity and sensitivity of laboratories in the detection of norovirus.

To assess the ability of the laboratories to detect different norovirus genogroups.

Total Number of Challenges: 2
Number of Panel Members: 5
Distribution / Testing Period: Q2 & Q4
Sample NA Target Source Cultured and/or Clinical material
Matrix Panel Format Transport Medium and/or Physiological Buffer and/or Synthetic Faecal Matrix
Panel Member Target Range Covering clinical range
Panel Member Sample Volume 1.0 ml TM, 0.1 ml Buffer
Panel Sample Pre-treatment Requirement NA samples are ready for analysis. Pre- treatment may be needed for SFM.Follow manufacturers IFU.
Panel Analysis Type Qualitative
Panel Testing Evaluated by various molecular methodologies
Storage / Shipment Conditions <-20°C / Frozen on Dry-ice
Accreditation / Regulatory Status Accredited to ISO 17043

$1,228.58